1. Goeieman DS, Mash R, Gloeck NR, Scheibe A. Characteristics of women on opioid substitution therapy in primary healthcare in Tshwane (South Africa): a retrospective observational study. BJGP Open.2025.E-pub. Impact factor 2.17.

2. Scheibe A, Steingo J, Grace G, Savva H, Sonderup M, Hausler H, Spearman CW. Feasibility of implementing viral hepatitis services into a correctional service facility in Cape Town, South Africa. International Journal of Drug Policy. 2025;137:104710. Impact factor 5.01. https://doi.org/10.1016/j.drugpo.2025.104710

3. Schluth CG, Rosen JG, Mcingana M, Rucinski KB, Knox JR, Comins CA, Steingo J, Shipp L, Makama S, Phetlhu DR, Mishra S, Hausler H, Baral SD, Schwartz SR. Longitudinal patterns and predictors of opioid and stimulant use initiation and cessation among female sex workers living with HIV in South Africa. Drug and Alcohol Dependence. 2025;269:112593. Impact factor 3.9. https://doi.org/10.1016/j.drugalcdep.2025.112593

4. Bhoora U, An Y, Owczarzak J, Ndini P, Moyo D, Shelly S, Marcus TS, Steiner L, Corcoran PC, Pollock S, Lefoka MH, Mabuto T, Hugo J, Hoffmann CJ. Pilot of Methadone for Recently Incarcerated People with Human Immunodeficiency Virus and Opioid Use in South Africa. J Correct Health Care. 2025. Impact factor 0.8. https://doi.org/10.1089/jchc.24.11.0096

5. Lefoka MG, Netangaheni RT. Experiences of women who inject Nyaope residing in the City of Tshwane Municipality, Gauteng. Health SA Gesondheid. 2025;30(0):a2760. Impact factor 1.1. https://doi.org/10.4102/hsag.v30i0.2760

1. Nyashanu, T, Scheibe A, Visser M. I Went for Rehab Many Times and It Never Worked, but the Harm Reduction Process Has given Me Renewed Hope’. Perceptions on the Effectiveness of Harm Reduction and Community‐based Opioid Substitution Therapy. Health Promotion Journal of Australia. 2023;35(3):653-661. Impact factor 1,9. https://doi.org/10.1002/hpja.789

2. Scheibe, A, Shelly, S and Stowe, MJ. Insights into the Value of the Market for Cocaine, Heroin and Methamphetamine in South Africa. Journal of Illicit Economies and Development. 2024;5(1):70-86. Impact factor 1,6. https://doi.org/10.31389/jied.156

3. Mutai KK, Stone J, Scheibe A, Fraser H, Johnson LF, Vickerman P. Trends and factors associated with illicit drug use in South Africa: Findings from multiple national population-based household surveys, 2002–2017 International Journal of Drug Policy. 2024;125:104352. Impact factor 5,01. https://doi.org/10.1016/j.drugpo.2024.104352

4. Scheibe A, Teixeira A, Djalo MA, Pereira MN, Barreto KR, Ba I, Bird L, Eligh J. Drug use patterns and health problems among people who use drugs in Guinea-Bissau (2022): A cross-sectional survey using respondent-driven sampling. International Journal of Drug Policy. 2024;134(104648). Impact factor 5.01. https://doi.org/10.1016/j.drugpo.2024.104648

5. Lujintanon S, Hausler H, Comins C, Mcingana M, Shipp L, Phetlhu D, Makama S, Guddera V, Mishra S, Baral S, Schwartz S Estimating the mortality risk correcting for high loss to follow-up among female sex workers with HIV in Durban, South Africa, 2018-2021. Annals of Epidemiology. 2024;92:8-16. Impact factor 5.6. https://doi.org/10.1016/j.annepidem.2024.02.006

1. Goeieman DS, Nonyane DS, Nzaumvila DK, Janse van Rensburg MNS. Retention of service users on opioid substitution therapy in the City of Tshwane, South Africa. PHCFM. 2023;15(1):a3392. Impact factor: 0,57. https://doi.org/10.4102/phcfm.v15i1.3392

2. Swanepoel I, Crafford, Geyer S, Marcus T. A pre-experimental design evaluation of brief harm reduction interventions to improve coping self-efficacy of carers of people with substance use disorder. Harm Reduction Journal. 2023;20:76. Impact factor: 4,22. https://doi.org/10.1186/s12954-023-00811-z

3. Swanepoel I, Geyer S, Marcus T. The Impact of Substance Use Disorders on Families and Carers: A Scoping Review. African Journal of Drug and Alcohol Studies. 2023;21. Impact factor: 0,2. https://dx.doi.org/10.4314/ajdas.v21i1-2.3

4. An Y, Hoffmann CJ, Bhoora U, Ndini P, Moyo D, Steiner L, Tshuma S, Mabuto T, Hugo J, Owczarzak J, Marcus TS. Opioid use and HIV treatment services experiences among male criminal justice-involved persons in South Africa: a qualitative study. Harm Reduction Journal. 2023;20:90. Impact factor: 4,36. https://doi.org/10.1186/s12954-023-00834-6

5. Siemens J-M A, Bhoora U, Janse van Rensburg MNS. Methadone use for acute opioid withdrawal in Tshwane shelters during the COVID-19 lockdown. SAFPJ. 2023;65(1):a5708. Impact factor: 0,68. https://doi.org/10.4102/safp.v65i1.5708

6. Scheibe A, Ncube L, Nonyan D, Coetzee-Spies M, Marcus T. Community Oriented Substance Use Programme in the City of Tshwane: A Cross-Sectional Survey of Stakeholder Perceptions. Southern African Journal of Social Work and Social Development. 2023;35(3):1-19. Impact factor: 0,404. https://doi.org/10.25159/2708-9355/13358

1. Wilson M, Amanda Brumwell A, Stowe M-J, Shelly S, Scheibe A. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs. Harm Reduction Journal. 2022;19(17):1-10. Impact factor: 4,279. https://doi.org/10.1186/s12954-021-00561-w

2. Ransing R, de la Rosa PA, Pereira-Sanchez V, Handuleh JIM, Jerotic S, Gupta AK, Karaliuniene R, de Filippis R, Peyron E, Boujraf S, Yee A, Vahdani B, Shoib S, Stowe MJ, Jaguga F, Dannatt L, da Silva AK, Grandinetti P, Jatchavala C. Current state of cannabis use, policies, and research across sixteen countries: Cross-Country Comparisons and International perspectives. Trends in Psychiatry and Psychotherapy. 2022;44(suppl 1):e20210263. Impact factor: 1,5. http://dx.doi.org/10.47626/2237-6089-2021-0263

3. Lefoka MH, Netangaheni RT. "Factors associated with smoking and transitioning to nyaope injection amongst women in the City of Tshwane Municipality: A self-report by women". Health SA Gesondheid. 2022;27:a1775. Impact factor: 0,615. https://doi.org/10.4102/hsag.v27i0.1775

4. Stowe M-J, Feher O, Vas B, Kayastha S, Greer A. The challenges, opportunities and strategies of engaging young people who use drugs in harm reduction: Insights from young people with lived and living experience. Harm Reduction Journal. 2022;19:83. Impact factor: 4.22. https://doi.org/10.1186/s12954-022-00663-z

5. Tlali M, Scheibe A, Ruffieux Y, Cornell M, Wettstein AE, Egger M, Davies M-A, Maartens G, Johnson LF, Haas AD. Diagnosis and treatment of opioid-related disorders in a South African private sector medical insurance scheme: A cohort study. International Journal of Drug Policy. 2022;109:103853. Impact factor: 5,931.https://doi.org/10.1016/j.drugpo.2022.103853

6. Bhoora U, Gloeck NR, Scheibe A. Managing acute opioid withdrawal with tramadol during COVID-19 lockdown in a peri-urban setting. PHCFM. 2022;14(1). Impact factor: 1,5.

7. Shelly S, Ebiti NW. Coming clean: Saying 'know' to drugs - Part III. South African General Practitioner. 2022;3(4):133-135. Impact factor: 0,1. https://doi.org/10.36303/SAGP.2022.3.4.0138

1. Gloeck N, Harris BN, Webb EM, Scheibe A. Factors predicting retention among people with opioid use disorders accessing outpatient methadone maintenance therapy in Tshwane, South Africa. SAMJ. 2021;111(1):68-73. Impact Factor 1.5. https://hdl.handle.net/10520/ejc-m_samj-v111-n1-a18

2. Dannatt L, Ransing R, Calvey T, Scheibein F, Saad NA, Shirasaka T, Ramalho R, Pant S, Vadivel R, Siste K, Stowe MJ, Kalita KN, Boujraf S, Testa R, Arya S, Morgan N, Grandinetti P. The Impact of Stigma on Treatment Services for People With Substance Use Disorders During the COVID-19 Pandemic—Perspectives of NECPAM Members. Frontiers in Psychiatry. 2021;12(223):1-4. Impact Factor 3,532. https://pmc.ncbi.nlm.nih.gov/articles/PMC7982835/pdf/fpsyt-12-634515.pdf

1. Scheibe A, Shelly S, Gerardy T, von Homeyer Z, Schneider A, Padayachee K, Naidoo SB, Mtshweni K, Matau A, Hausler H, Marks M. Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa. Addiction Science & Clinical Practice. 2020;15(13):1-11. Impact factor 1.106. https://doi.org/10.1186/s13722-020-00186-7

2. Marks M, Scheibe A, Shelly S. High retention in an opioid agonist therapy project in Durban, South Africa: the role of best practice and social cohesion. Harm Reduction Journal. 2020;17:25. Impact factor 1.64. https://doi.org/10.1186/s12954-020-00368-1

3. Scheibe A, Shelly S, Hugo J, Mohale M, Lalla S, Renkin W, Gloeck N, Khambule S, Kroucamp L, Bhoora U, Marcus TS. Harm reduction in practice – The Community Oriented Substance Use Programme in Tshwane. PHCFM. 2020;12(1):s2285. Impact factor 1.5. https://doi.org/10.4102/phcfm.v12i1.2285

4. Stowe M-J, Scheibe A, Shelly S, Marks M. Covid-19 restrictions and increased risk of overdose for street-based people with opioid dependence in South Africa. SAMJ. 2020;110(6):434. Impact factor 1.5. https://doi.org/10.7196/SAMJ.2020.v110i6.14832

5. Scheibe A, Shelly S, Versfeld A. In J. Buxton, M. Chinery-Hesse and K. Tinasti (Eds)), Drug Policies and Development: Conflict and Coexistence Prohibitionist Drug Policy in South Africa—Reasons and Effects. International Development Policy. 2020;12. Impact factor 1.225. https://doi.org/10.4000/poldev.4007

6. Scheibe A, Young K, Versfeld A, Spearman WC, Sonderup MW, Prabdial-Sing N, Puren A, Hausler H. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017). BMC Infectious Diseases. 2020;20:655. Impact factor 2.580. https://doi.org/10.1186/s12879-020-05359-y

7. Stowe MJ, Calvey T, Scheibein F, Arya S, Saad NA, Shirasaka T, Dannatt L, Ghosh A, Yee A, Ratta-apha W, Vadivel R, Siste K, Shah B, Ramalho R, Narasimha VL, Delic M, Peyron E, Gumikiriza- Onoria JL, Pant SP, Boujraf S,Grandinetti P, Morgan N. Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs. Journal of Addiction Medicine. 2020;14(6):e287-e289. Impact factor 3.014. https://journals.lww.com/journaladdictionmedicine/Abstract/2020/12000/Access_to_Healthcare_and_Harm_Reduction_Services.8.aspx

8. Calvey T, Scheibein F, Saad NA, Shirasaka T, Dannatt L, Stowe MJ, Shah B, Narasimha VL, Brushchi A, Peyron E, Gumikiriza-Onoria JL, Ghosh A, Pant SB, Yee A, Ratta-apha W, Vadivel R, Siste K, Maiti T, d Boujraf S, Grandinetti P, Morgan N, Arya S. The changing landscape of alcohol use disorder following COVID-19 restrictions- Perspectives of early career professionals in 16 countries. Journal of Addiction Medicine. 2020;14(6):e284-e286. Impact factor 3.014.

9. Moshenska G, Shelly S. Notes for an Archaeology of Discarded Drug Paraphernalia. Archaeology International. 2020;23(1):104-121. Impact factor 0.47. https://doi.org/10.14324/111.444.ai.2020.09

1. Shelly S, Howell S. Perpetuating apartheid: South African drug policy. In: Koram K, (Ed), The War on Drugs and the Gloval Colour Line. London:Pluto Press; 2019:156-176. https://doi.org/10.2307/j.ctvdmwxn7

2. Southwell M, Shelly S, Macdonald V, Verster A, Maher L. Transforming lives and empowering communities: evidence, harm reduction and a holistic approach to people who use drugs. Current Opinion in HIV and AIDS. 2019;14:1-6. Impact factor 4.268. https://journals.lww.com/co-hivandaids/abstract/2019/09000/transforming_lives_and_empowering_communities_11.aspx

3. United Nations Office on Drugs and Crime (Shaun Shelly Co-author). HIV Prevention, Treatment, Care and Support for People Who Use Stimulant Drugs. TECHNICAL GUIDE. UNODC; Vienna;2019:1-76. https://www.unodc.org/documents/hiv-aids/publications/People_who_use_drugs/19-04568_HIV_Prevention_Guide_ebook.pdf

4. Scheibe AP, Gloeck NR, Shelly S, Marcus TS, Hugo J. The prevalence and characteristics of moderate- to high-risk regulated and unregulated substance use among patients admitted to four public hospitals in Tshwane, South Africa. SAMJ. 2019;109(12):971-977. Impact factor 1,325. https://doi.org/10.7196/SAMJ.2019.v109i12.13870

5. Hugo JFM. Chapter 4: Reducing harm for users of heroin in Tshwane: Some reflections about health justice, communities and medical care In: Waetjam T (ed). Opioids in South Africa: Towards a policy of harm reduction. HSRC Press. 2019;Part 2(Chapter 4):52-65. Impact factor. https://hsrcpress.ac.za/product/opioids-in-south-africa-towards-a-policy-of-harm-reduction/

6. Versfeld A, Beukes E, Gallant C, Beukes A, Cookson M, Titus J, Maree M, Benjamin R, Shelly S. Complexities, hopes, possibilities - People who use drugs doin research in Cape Town: Reflectdions on inclusion and methodologies. In: Waetjam T (ed). Opioids in South Africa: Towards a policy of harm reduction. HSRC Press. 2019; Part 3(Chapter 8):109-118. Impact factor. https://hsrcpress.ac.za/product/opioids-in-south-africa-towards-a-policy-of-harm-reduction/

1. Scheibe A., Marks M., Shelly S., Gerardy T., Domingo AK. & Hugo J. Developing an advocacy agenda for increasing access to opioid substitution therapy as part of comprehensive services for people who use drugs in South Africa. SAMJ. 2018;108(10):800-802. Impact factor 1.5. https://tbhivcare.org/publications/developing-an-advocacy-agenda-for-increasing-access-to-opioid-substitution-therapy-as-part-of-comprehensive-services-for-people-who-use-drugs-in-south-africa/

1. Marks M, Gumede S. & Shelly S. Drugs are the solution not the problem: exploring drug use rationales and the need for harm reduction practices South Africa. Acta Criminologica Southern African Journal of Criminology. 2017;30(5):1-14. http://hdl.handle.net/2263/65256